Page 12 - Envision November-December 2020
P. 12
A Brighter Future
KIDS WITH MYOPIA
for
Special Report
By JoAnne Sommers
lthough the incidence of myopia has risen to epidemic proportions,
it can be challenging for eyecare professionals (ECPs) to offer hope.
They can now take heart, knowing that CooperVision’s Brilliant
Futures™ Myopia Management Program, featuring MiSight® 1 day
Acontact lenses, launched in Canada in November 2020.
MiSight 1 day, the first and only contact lens clinically proven to slow the
progression of myopia in age-appropriate children, is approved by the U.S. Food
and Drug Administration and authorized for sale by Health Canada for this
purpose. Building on its success in the United Kingdom, Spain and Australia,
the Brilliant Futures program gives optometrists an effective way to treat young
patients, while also raising awareness of myopia and the importance of regular
comprehensive eye exams with parents.
Let’s take a look at the extent of the myopia problem in Canada, before learning
how the Brilliant Futures program can make it easy for ECPs to address myopia
in their practices.
The first population-based study designed to examine myopia prevalence in
Canadian school-aged children, conducted by the Centre for Ocular Research
& Education (CORE) at the University of Waterloo’s School of Optometry and
Vision Science, and the Canadian National Institute for the Blind, sheds light on
the prevalence of myopia in Canadian children. This ground-breaking research
found that the rise of immigration (adding three million people a year to our
12 / NOVEMBER - DECEMBER 2020 / www.ENVISIONMAGAZINE.ca /
